Seamless Transition

Home > Clinical Services > EU & UK QP Release > Seamless Transition
f6oSvaKU_708x531_1

Seamless Transition

Seamless continuity across the product lifecycle

The release of IMP products into use for clinical trials demands a seamless release, which means a joined-up service from project setup to batch certification, right through the supply chain, and finally on to the end user.

We serve as UK, EU and Global IMP distribution hubs for many global clients.

Storage and distribution facilities providing controlled ambient, cold chain and frozen storage areas (15-25°C, 2-8°C, -20°C, -80°C).

Enquire Today

IVRS/IWRS support and integration

  • Local storage depots in Sydney and Melbourne – Australia, Austria, Spain, North America, Canada and Brazil, as well as fully owned depots in Ireland and our HQ in the UK offer seamless UK, EU and global distribution
  • A wide range of approved couriers to provide same day, direct, next day and cold chain shipments
  • Validated transport shippers
  • Management of all IMP returns and destruction
  • Coherent team of UK and EU QPs working within a common quality system ensuring smooth transition of IMPs across UK and EU boundaries
  • A 24/7 emergency logistics contact is provided to all clients to manage any unexpected distribution issues during the study.
Request chat with QP

Our Other Services

Formulation Development

Eramol offers clinical formulation development and manufacturing services to enable you to develop your product and speed up your time to market. We’ll work with you to develop an effective formulation – either in solid tablet, capsule or liquid form – giving you optimal clinical outcomes that can support your product across all clinical trial phases.

Sterile Manufacturing

Eramol delivers a purpose-built, EU GMP Annex 1–compliant sterile manufacturing service dedicated to Phase I and Phase II clinical trial supply. Our facility is designed for agility, reliability, and regulatory strength by integrating advanced isolator technology, closed-system processing, moist heat terminal sterilisation and a full end-to-end clinical supply chain — ensuring your sterile injectable, cartridges and pre filled syringes reach patients safely, on time and in full regulatory compliance.

Non Sterile Manufacturing

GMP Production of Tablets, Capsules & Oral Liquids for Phase I–III and Commercial Supply Eramol delivers end-to-end non-sterile manufacturing built on a foundation of quality, regulatory expertise, and Qualified Person (QP) leadership. Our Sevenoaks GMP facility, commissioned in November 2021 and operational since August 2022, supports the full product lifecycle—from early-phase clinical development right through to commercial supply.

Clinical Packaging

We recognise that the challenge of acquiring adequate placebos is considerable, whether it be matching a placebo or making an active comparator.

Labelling Solutions

Our versatile and extensive labelling solutions have been designed to offer flexibility, economy of scale and to meet the demands of last-minute requirements.

EU & UK QP Release

QP Release is a critical stage in clinical trials: it is the process whereby Qualified Persons (QPs) ensure that a batch of investigative medicinal products (IMPs) that has been manufactured are of a high enough quality that they can be released for use in clinical trials.

Reliable. Proven. Safe. Effective.

logoipsum
logoipsum
logoipsum-265
logoipsum-244
logoipsum-238 (1)
logoipsum-254
logoipsum-297

Reliable. Proven. Safe. Effective.

logoipsum
logoipsum
logoipsum-265
logoipsum-244
logoipsum-238 (1)
logoipsum-254
logoipsum-297

Speak With Us

Products on online services or over the Internet. Electronic commerce draws on
technologies such as mobile commerce application

Scroll to Top

Email

enquiry.uk@eramol.com

Phone

+44 (0) 1293 368080